BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24661838)

  • 1. Circulating MicroRNAs in blood of patients with prostate cancer.
    Medina-Villaamil V; Martínez-Breijo S; Portela-Pereira P; Quindós-Varela M; Santamarina-Caínzos I; Antón-Aparicio LM; Gómez-Veiga F
    Actas Urol Esp; 2014 Dec; 38(10):633-9. PubMed ID: 24661838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential blood-based diagnosis between benign prostatic hyperplasia and prostate cancer: miRNA as source for biomarkers independent of PSA level, Gleason score, or TNM status.
    Leidinger P; Hart M; Backes C; Rheinheimer S; Keck B; Wullich B; Keller A; Meese E
    Tumour Biol; 2016 Aug; 37(8):10177-85. PubMed ID: 26831660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Panel of MicroRNAs as Diagnostic Biomarkers for the Identification of Prostate Cancer.
    Daniel R; Wu Q; Williams V; Clark G; Guruli G; Zehner Z
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28621736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer.
    Wang L; Liu Y; Du L; Li J; Jiang X; Zheng G; Qu A; Wang H; Wang L; Zhang X; Liu H; Pan H; Yang Y; Wang C
    Mol Med Rep; 2015 Jul; 12(1):615-22. PubMed ID: 25738263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protocol for serum exosomal miRNAs analysis in prostate cancer patients treated with radiotherapy.
    Malla B; Aebersold DM; Dal Pra A
    J Transl Med; 2018 Aug; 16(1):223. PubMed ID: 30103771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating microRNAs as biomarkers of adult Crohn's disease.
    Jensen MD; Andersen RF; Christensen H; Nathan T; Kjeldsen J; Madsen JS
    Eur J Gastroenterol Hepatol; 2015 Sep; 27(9):1038-44. PubMed ID: 26230660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease.
    Selth LA; Townley S; Gillis JL; Ochnik AM; Murti K; Macfarlane RJ; Chi KN; Marshall VR; Tilley WD; Butler LM
    Int J Cancer; 2012 Aug; 131(3):652-61. PubMed ID: 22052531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of esophageal squamous cell carcinoma.
    Yang M; Liu R; Sheng J; Liao J; Wang Y; Pan E; Guo W; Pu Y; Yin L
    Oncol Rep; 2013 Jan; 29(1):169-76. PubMed ID: 23124769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiling analysis of circulating microRNA in peripheral blood of patients with class IV lupus nephritis.
    Navarro-Quiroz E; Pacheco-Lugo L; Navarro-Quiroz R; Lorenzi H; España-Puccini P; Díaz-Olmos Y; Almendrales L; Olave V; Gonzalez-Torres H; Diaz-Perez A; Dominguez A; Iglesias A; García R; Aroca-Martinez G
    PLoS One; 2017; 12(11):e0187973. PubMed ID: 29136041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA values in children with rheumatic carditis: a preliminary study.
    Gumus G; Giray D; Bobusoglu O; Tamer L; Karpuz D; Hallioglu O
    Rheumatol Int; 2018 Jul; 38(7):1199-1205. PubMed ID: 29845432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.
    Schaefer A; Jung M; Mollenkopf HJ; Wagner I; Stephan C; Jentzmik F; Miller K; Lein M; Kristiansen G; Jung K
    Int J Cancer; 2010 Mar; 126(5):1166-76. PubMed ID: 19676045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum MiRNA panel as potential biomarkers for chronic hepatitis B with persistently normal alanine aminotransferase.
    Tan Y; Ge G; Pan T; Wen D; Gan J
    Clin Chim Acta; 2015 Dec; 451(Pt B):232-9. PubMed ID: 26483130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low-risk, localized prostate cancer.
    Nguyen HC; Xie W; Yang M; Hsieh CL; Drouin S; Lee GS; Kantoff PW
    Prostate; 2013 Mar; 73(4):346-54. PubMed ID: 22887127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of circulating MicroRNA 141 to circulating tumor cells, lactate dehydrogenase, and prostate-specific antigen for determining treatment response in patients with metastatic prostate cancer.
    Gonzales JC; Fink LM; Goodman OB; Symanowski JT; Vogelzang NJ; Ward DC
    Clin Genitourin Cancer; 2011 Sep; 9(1):39-45. PubMed ID: 21723797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of plasma microRNAs as a biomarker of sporadic Amyotrophic Lateral Sclerosis.
    Takahashi I; Hama Y; Matsushima M; Hirotani M; Kano T; Hohzen H; Yabe I; Utsumi J; Sasaki H
    Mol Brain; 2015 Oct; 8(1):67. PubMed ID: 26497046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OncoUroMiR: Circulating miRNAs for Detection and Discrimination of the Main Urological Cancers Using a ddPCR-Based Approach.
    Sequeira JP; Barros-Silva D; Ferreira-Torre P; Salta S; Braga I; Carvalho J; Freitas R; Henrique R; Jerónimo C
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05).
    Joerger M; Baty F; Früh M; Droege C; Stahel RA; Betticher DC; von Moos R; Ochsenbein A; Pless M; Gautschi O; Rothschild S; Brauchli P; Klingbiel D; Zappa F; Brutsche M
    Lung Cancer; 2014 Aug; 85(2):306-13. PubMed ID: 24928469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of microRNAs in basal cell carcinoma.
    Sand M; Skrygan M; Sand D; Georgas D; Hahn SA; Gambichler T; Altmeyer P; Bechara FG
    Br J Dermatol; 2012 Oct; 167(4):847-55. PubMed ID: 22540308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human miR-1228 as a stable endogenous control for the quantification of circulating microRNAs in cancer patients.
    Hu J; Wang Z; Liao BY; Yu L; Gao X; Lu S; Wang S; Dai Z; Zhang X; Chen Q; Qiu SJ; Wu Y; Zhu H; Fan J; Zhou J; Wang J
    Int J Cancer; 2014 Sep; 135(5):1187-94. PubMed ID: 24488924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Levels of hsa-miR-619-5p and hsa-miR-1184 Differ in Prostatic Benign Hyperplasia and Cancer.
    Knyazev EN; Fomicheva KA; Mikhailenko DS; Nyushko KM; Samatov TR; Alekseev BY; Shkurnikov MY
    Bull Exp Biol Med; 2016 May; 161(1):108-11. PubMed ID: 27265125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.